Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics (PRQR) Equity Income (2021 - 2022)

Historic Equity Income for ProQR Therapeutics (PRQR) over the last 2 years, with Q1 2022 value amounting to -$8978.7.

  • ProQR Therapeutics' Equity Income fell 10695.66% to -$8978.7 in Q1 2022 from the same period last year, while for Dec 2022 it was -$8978.7, marking a year-over-year decrease of 10722.59%. This contributed to the annual value of -$8162.0 for FY2022, which is 9682.16% up from last year.
  • Per ProQR Therapeutics' latest filing, its Equity Income stood at -$8978.7 for Q1 2022, which was down 10695.66% from $97237.5 recorded in Q4 2021.
  • In the past 5 years, ProQR Therapeutics' Equity Income registered a high of $155665.9 during Q3 2021, and its lowest value of -$257714.1 during Q2 2021.